The Joint (JYNT)
(Delayed Data from NSDQ)
$10.64 USD
+0.21 (2.01%)
Updated Jan 3, 2025 04:00 PM ET
After-Market: $10.60 -0.04 (-0.38%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
JYNT 10.64 +0.21(2.01%)
Will JYNT be a Portfolio Killer in January?
Zacks Investment Research is releasing its prediction for JYNT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for JYNT
JYNT's Q3 Earnings Meet Estimates Amid Higher Costs, Shares Dip 3%
The Joint Corp. (JYNT) Q3 Earnings Match Estimates
JYNT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates
Centene (CNC) Q3 Earnings and Revenues Beat Estimates
UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates
Other News for JYNT
The Joint Corp.: Growth Story Shows Cracks, Downgrade To Hold
The Joint Corp (JYNT) Shares Up 6.83% on Jan 1
Bandera Partners LLC Acquires Significant Stake in Innovative Food Holdings Inc
Hold Rating Amidst Uncertainty and Transitional Challenges in Q3 2024
Analysts Are Bullish on These Healthcare Stocks: Joint (JYNT), Cadrenal Therapeutics, Inc. (CVKD)